Nitroprusside has no effect on t-PA and PAI production and release by endothelial cells in culture

Fibrinolysis

Volumn 10, Issue 2, 1996, Pages 111-115

  Pannocchia, A ^a,b   Garis, G ^a   Giorgianni, A ^a,b   Stella, S ^a   Bosia, A ^a,b   Ghigo, D ^a,b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NITROPRUSSIDE SODIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRINOLYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE; UMBILICAL VEIN;

EID: 0029885711     PISSN: 02689499     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(96)80086-5     Document Type: Article

References (21)

1. Kruitof E K O. Plasminogen activator inhibitor type 1. Biochemical, biological and chemical aspects. Fibrinolysis 1988; 2: 59-70.
2. Pannekoek H, de Vries C, van Zanneveld A J. Mutants of human tissue-type plasminogen activator (t-PA). Structural aspects and functional properties. Fibrinolysis 1988; 2: 123-132.
3. Krause J. Catabolism of tissue type plasminogen activator (t-PA) its variants, mutants and hybrids. Fibrinolysis 1988; 2: 133-142.
4. Emeis J J. Mechanism involved in short term change in blood levels of t-PA. In: Kluft C. (ed) Tissue type plasminogen activator (t-PA): physiological and clinical aspects. Vol II. Boca Raton, CRC Press 1988: 21-35.
5. Erickson L A, Ginsberg M H, Loskutoff D J. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest 1984; 74: 1465-1472.
6. Fay W P, Owen W G 1989 Platelet plasminogen activator inhibitor: purification and characterization of interaction with plasminogen activators and activated protein C. Biochemistry 1989; 28: 5773-5778.
7. Booth N A, Simpson A J, Croll A, Bennett B, McGregor I R. Plasminogen activator inhibitor (PAI-1) in plasma and platelets. Brit J Haematol 1988; 70: 327-333.
8. Torr-Brown S R, Sobel B E. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets. Thromb Res 1993; 72: 413-421.
9. Moncada S, Gryglewski R, Bunting S, Vane J R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665.
10. Palmer R M J, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
11. Millian B T, Ignarro L J, Ohlstein E H, Pontecorvo E G, Hyman A L, Kadowitz P J. Evidence for the inhibitor role of guanosine 3′-5′ monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-955.
12. Moncada S, Palmer R M J, Higgs E A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-142.
13. Korbut R, Lidburg P S, Vane J R. Prolongation of fibrinolytic activity of tissue plasminogen activator by nitrovasodilators. The Lancet 1990; 335: 669.
14. Lidburg P S, Korbut R, Vane J R. Sodium nitroprusside modulates the fibrinolytic system in the rabbit. Brit J Pharmacol 1990; 101:527-530.
15. Stamler J S, Simon D I, Jerak O et al. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. PNAS 1992; 89: 8087-8091.
16. Metha J L, Nicolini F A, Nichols W W, Saldem T G P. Concurrent nitroglycerin administration decreases thrombolytic potential of tissue-type plasminogen activators. J Am Coll Cardiol 1991; 17: 805-811.
17. Abrams J. Nitrates. Med Clin North Am 1988; 72: 1-35.
18. Jaffe E A, Nachman R L, Becker C G, Minick C R. Culture of human endothelial cells derived from humbilical veins. J Clin Invest 1973; 52:2745-2756.
19. Deklerk P J, Alessi M C, Verstreken M, Kruithoff E K O, Vague I, Collen D. Measurement of plasminogen activator inhibitor-1 in biological fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-225.
20. Verheijeen J H, Mullaart E, Chang G T G, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1992; 48: 266-269.
21. Nicolini F A, Ferrini D, Ottani F et al. Concurrent nitroglycerin therapy impairs tissue-type plasminogen activator-induced thrombolysix in patients with acute myocardial infarction. Am J Cardiol 1994; 74: 662-666.